“Sizable Upside Potential”: 5 Biotech Stocks Under $10 For Aggressive Investors
“These are five stocks for aggressive investors looking to get share count leverage on biotech companies that have sizable upside potential,” says the author of today’s article of the five biotech stocks he highlights – all of which are trading under the $10 level and are rated “Overweight” at Oppenheimer. For these five biotech stocks, CLICK HERE.
